Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 10/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.52 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.52 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL183875 | 0.89 | FTO (0.52) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL11310755 | 0.89 | FTO (0.52) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL7646663 | 0.89 | FTO (0.52) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL9428188 | 0.86 | FTO (0.56) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL5149281 | 0.85 | FTO (0.55) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL9427469 | 0.85 | HPGD (0.56) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL1254421 | 0.85 | FTO (0.64) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL905219 | 0.84 | FTO (0.47) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL4885766 | 0.84 | FTO (0.47) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL15778575 | 0.84 | FTO (0.47) | FTOMAPTHPGDMEN1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4348347-A2 | SYSTEM AND METHOD FOR HIGH RESOLUTION 3D NANOFABRICATION | Irradiant Technologies Inc. (US) | 2024-04-10 | — | — | EP | claimed |
| WO-2022251546-A2 | SYSTEM AND METHOD FOR HIGH RESOLUTION 3D NANOFABRICATION | Irradiant Technologies Inc. (US) | 2022-12-01 | — | — | WO | claimed |
| EP-0853680-B1 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | EMD BIOSCIENCES INC (US) | 2004-03-31 | — | — | EP | claimed |
| EP-0853680-A4 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | NOVAGEN INC (US) | 2000-09-13 | — | — | EP | claimed |
| EP-0853680-A1 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | NOVAGEN, INC. (US) | 1998-07-22 | — | — | EP | claimed |
| WO-1997012994-A1 | METHOD FOR PRECIPITATING NUCLEIC ACID WITH VISIBLE CARRIER | NOVAGEN, INC. (US) | 1997-04-10 | — | — | WO | claimed |
| US-20220389478-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | ORYZON GENOMICS SA (ES) | 2022-12-08 | — | — | US | disclosed |
| US-11034991-B2 | Methods to determine KDM1A target engagement and chemoprobes useful therefor | ORYZON GENOMICS S.A. (ES) | 2021-06-15 | — | — | US | disclosed |
| US-10736943-B2 | Silk microspheres for encapsulation and controlled release | TRUSTEES OF TUFTS COLLEGE (US) | 2020-08-11 | — | — | US | disclosed |
| US-20190085372-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | ORYZON GENOMICS SA (ES) | 2019-03-21 | — | — | US | disclosed |
| EP-3430015-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | Oryzon Genomics, S.A. (ES) | 2019-01-23 | — | — | EP | disclosed |
| WO-2017158136-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | ORYZON GENOMICS, S.A. (ES) | 2017-09-21 | — | — | WO | disclosed |
| CN-107007835-A | Carry Prussian blue targeted nano compound and preparation method thereof | 重庆医科大学 | 2017-08-04 | — | — | CN | disclosed |
| EP-0689684-A1 | CHEMICAL FUNCTIONALIZATION OF POLYMERS | THE STATE OF OREGON acting by and through THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) | 1996-01-03 | — | — | EP | disclosed |
| US-5464746-A | Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives | ABBOTT LABORATORIES (US) | 1995-11-07 | — | — | US | disclosed |
| WO-1995009239-A2 | PRODUCTION, PURIFICATION, CLEAVAGE AND USE OF FUSION PEPTIDES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1995-04-06 | — | — | WO | disclosed |
| WO-1995003296-A1 | HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR CARBAZOLE AND DIBENZOFURAN DERIVATIVES | ABBOTT LABORATORIES (US) | 1995-02-02 | — | — | WO | disclosed |
| EP-0623174-A1 | HOMOCYSTEINE ASSAY. | COCKBAIN JULIAN R M (GB) | 1994-11-09 | — | — | EP | disclosed |
| WO-1994022053-A1 | CHEMICAL FUNCTIONALIZATION OF POLYMERS | THE STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) | 1994-09-29 | — | — | WO | disclosed |
| WO-1993015220-A1 | HOMOCYSTEINE ASSAY | AXIS BIOCHEMICALS AS (NO) | 1993-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220389478-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | KDM1B, KDM1A, KDM7A | FTO 778/4885MAPT 4545/4885HPGD 3810/4885 |
| US-20190085372-A1 | METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR | KDM1B, KDM1A, KDM7A | FTO 778/4885MAPT 4545/4885HPGD 3810/4885 |
| US-11034991-B2 | Methods to determine KDM1A target engagement and chemoprobes useful therefor | KDM1B, KDM1A, KDM7A | FTO 778/4885MAPT 4545/4885HPGD 3810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.